skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Cardoso, F. ; Bartlett, J.M.S. ; Slaets, L. ; van Deurzen, C.H.M. ; van Leeuwen-Stok, E. ; Porter, P. ; Linderholm, B. ; Hedenfalk, I. ; Schröder, C. ; Martens, J. ; Bayani, J. ; van Asperen, C. ; Murray, M. ; Hudis, C. ; Middleton, L. ; Vermeij, J. ; Punie, K. ; Fraser, J. ; Nowaczyk, M. ; Rubio, I.T. ; Aebi, S. ; Kelly, C. ; Ruddy, K.J. ; Winer, E. ; Nilsson, C. ; Lago, L. Dal ; Korde, L. ; Benstead, K. ; Bogler, O. ; Goulioti, T. ; Peric, A. ; Litière, S. ; Aalders, K.C. ; Poncet, C. ; Tryfonidis, K. ; Giordano, S.H.

Annals of oncology, 2018-02, Vol.29 (2), p.405-417 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Viale, G. ; Slaets, L. ; Bogaerts, J. ; Rutgers, E. ; van't Veer, L. ; Piccart-Gebhart, M.J. ; de Snoo, F.A. ; Stork-Sloots, L. ; Russo, L. ; Dell'Orto, P. ; van den Akker, J. ; Glas, A. ; Cardoso, F.

Annals of oncology, 2014-04, Vol.25 (4), p.816-823 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

Annals of oncology, 2013-12, Vol.24 (12), p.2985-2989 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients

Bernard-Marty, C. ; Mano, M. ; Paesmans, M. ; Accettura, C. ; Munoz-Bermeo, R. ; Richard, T. ; Kleiber, K. ; Cardoso, F. ; Lobelle, J. P. ; Larsimont, D. ; Piccart, M. J. ; Di Leo, A.

Annals of oncology, 2003-05, Vol.14 (5), p.693-698 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
5
Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma
Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma

Filho, A. F. Ferreira ; Cardoso, F. ; Di Leo, A. ; Awada, A. ; Silva, V. D. da ; Tovar, R. B. ; Schwartsmann, G.

Annals of oncology, 2001-12, Vol.12 (12), p.1757-1759 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions
Material Type:
Artigo 		Adicionar ao Meu Espaço

The feasibility of classical cyclophosphamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: a study of consistency in relative dose intensity (RDI) and cumulative doses across institutions

Ferreira Filho, A. F. ; Di Leo, A. ; Paesmans, M. ; Beauduin, M. ; Vindevoghel, A. ; Michel, J. ; Focan, C. ; Awada, A. ; Cardoso, F. ; Dolci, S. ; Bartholomeus, S. ; Piccart, M. J.

Annals of oncology, 2002-03, Vol.13 (3), p.416-421 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

von Mehren, M. ; Schilder, R.J. ; Cheng, J.D. ; Temmer, E. ; Cardoso, T.M. ; Renshaw, F.G. ; Bayever, E. ; Zannikos, P. ; Yuan, Z. ; Cohen, R.B.

Annals of oncology, 2008-10, Vol.19 (10), p.1802-1809 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.